{"id":447314,"title":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T14:09:49.339000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/update-clinical-trial-sponsors-requirements-tuberculosis-screening-healthy-volunteers-phase-1-clinical-trials-involving-immunosuppressant-drugs.html?wbdisable=false","snippet":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties December 18, 2007 Our file number: 07-129093-226 (PDF Version - 20 K) Contact: OCT BEC Enquiries Notice On…","rawSnapshotUrl":"/api/snapshots/raw/447314","browseUrl":"https://replay.healtharchive.ca/job-6/20260103140949/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/update-clinical-trial-sponsors-requirements-tuberculosis-screening-healthy-volunteers-phase-1-clinical-trials-involving-immunosuppressant-drugs.html?wbdisable=false#ha_snapshot=447314","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}